Skip to main content
Article thumbnail
Location of Repository

The onset of labor alters corticotropin-releasing hormone type 1 receptor variant expression in human myometrium : putative role of interleukin-1ß\ud

By Danijela Markovic, Manu Vatish, Mei Gu, Donna Slater, Rob Newton, Hendrik Lehnert and Dimitris Grammatopoulos


CRH targets the human myometrium during pregnancy. The efficiency of CRH actions is determined by expression of functional receptors (CRH-R), which are dynamically regulated. Studies in myometrial tissue biopsies using quantitative RT-PCR demonstrated that the onset of labor, term or preterm, is associated with a significant 2- to 3-fold increase in CRH-R1 mRNA levels. Detailed analysis of myometrial CRH-R1 mRNA variants showed a decline of the pro-CRH-R1 mRNA encoding the CRH-R1ß variant during labor and increased mRNA levels of CRH-R1d mRNA. Studies in myometrial cells identified IL-1ß as an important regulator of myometrial CRH-R1 gene expression because prolonged treatment of myometrial cells with IL-1ß (1 ng/ml) for 18 h induced expression of CRH-R1 mRNA levels by 1.5- to 2-fold but significantly attenuated CRH-R1ß mRNA expression by 70%. In contrast, IL-1ß had no effect on CRH-R1d mRNA expression. Studies using specific inhibitors suggest that ERK1/2, p38 MAPK, and downstream nuclear translocation of nuclear factor-B mediate IL-1ß effects on myometrial CRH-R1 gene. However, the increased CRH-R1 mRNA expression was associated with a dampening of the receptor efficacy to activate the adenylyl cyclase/cAMP signaling cascade. Thus, our findings suggest that IL-1ß is an important regulator of CRH-R1 expression and functional activity, and this interaction might play a role in the transition of the uterus from quiescence to active contractions necessary for the onset of parturition. \u

Topics: RG
Publisher: The Endocrine Society
Year: 2007
OAI identifier:

Suggested articles


  1. (2001). A high-throughput study of gene expression in preterm labor with a subtractive microarray approach. doi
  2. (1999). A novel spliced variant of the type 1 corticotropin-releasinghormone(CRH)receptorwithadeletioninthe7thtransmembranedomain present in the human pregnant term myometrium and fetal membranes. doi
  3. (2001). Alternative splicing of CRH-R1 receptors in human and mouse skin: identification of new variants and their differential expression. doi
  4. (1999). Basal and interleukin-1 stimulated prostaglandin production from cultured human myometrial cells: differential regulation by corticotropin-releasing hormone. doi
  5. (2005). Chariot A doi
  6. (2001). Control of intracellular signalling by corticotropin-releasing hormone (CRH) in human myometrium. Front Horm Res doi
  7. (2005). Corticotropin-releasing hormone effects on human pregnant vs. nonpregnant myometriumexplantsestimatedfromamathematicalmodelofuterinecontraction.
  8. (1998). Corticotropin-releasing hormone receptor subtype 1 is significantly up-regulated at the time of labour in the human myometrium. doi
  9. (2000). Endocrine and paracrine regulation of birth at term and preterm. Endocr Rev 21:514–550 3212 Endocrinology, doi
  10. (2004). Expression and deoxyribonucleic acid-binding activity of the nuclear factor B family in the human myometrium during pregnancy and labor. doi
  11. (2004). Expression of urocortin II (UCNII) and identification of distinct corticotropin-releasing hormone type-2 receptor (CRH-R2) signalling pathways regulating myosin light chain phosphorylation in pregnant myometrial cells. doi
  12. (1999). Hillhouse EW doi
  13. (1998). Human CRH receptor: differences in subtype expression between pregnant and non-pregnant myometrium. doi
  14. (2004). In situ analysis of interleukin-1-induced transcription of COX-2 and IL-8 in cultured human myometrial cells. doi
  15. (1999). Induction of cyclooxygenase-2 expressioninhumanmyometrialsmoothmusclecellsbyinterleukin-1:involvement of p38 mitogen-activated protein kinase. doi
  16. (2002). Interleukin-1 induces phosphodiesterase 4B2 expression in human myometrial cells through a prostaglandin E2- and cyclic adenosine 3,5-monophosphate-dependent pathway. doi
  17. (2005). NF-B in human disease: current inhibitors and prospects for de novo structure based design of inhibitors. doi
  18. (2004). Promoter analysis of human corticotropin-releasing factor (CRF) type 1 receptor and regulation by CRF and urocortin. doi
  19. (2005). Regulation of the endothelin/endothelin receptor system by interleukin-1 in human myometrial cells. doi
  20. (1996). The biological activity of the corticotropin-releasing hormone receptor-adenylate cyclase complex in human myometrium is reduced at the end of pregnancy. doi
  21. (1995). The human myometrium expresses multiple isoforms of the corticotropin releasing hormone receptor. doi
  22. (1993). The identification of a human myometrial corticotropin-releasing hormone receptor which increases in affinity during pregnancy. doi
  23. (2005). The mitogen-activated protein kinase dependent expression of prostaglandin H synthase-2 and interleukin-8 messenger ribonucleic acid by myometrial cells: the differential effect of stretch and interleukin-1. doi
  24. (2006). The molecular mechanisms underlying the regulation of the biological activity of corticotropin-releasing hormone receptors: implications for physiology and pathophysiology. doi
  25. (1999). The nuclear transcription factor NF-B mediates interleukin-1-induced expression of cyclooxygenase-2 in human myometrial cells. doi
  26. (2002). Up-regulation of nitric oxide synthase and modulation of the guanylate cyclase activity by corticotropinreleasinghormoneinculturedhumanpregnantmyometrialcells. doi

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.